Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines

Busto, Usoa, Sellers, Edward M., Naranjo, Claudio A., Cappell, Howard, Sanchez-Craig, Martha, Sykora, Kathy · 1986 · New England Journal of Medicine

Abstract

We conducted a double-blind, placebo-controlled trail in which 40 patients who had undergone long-term therapy with benzodiazepines were switched to placebo or to diazepam in a dose approximately equivalent to their usual dose of the benzodiazepine; the dose of diazepam was then tapered during an eight-week period. Patients were assessed clinically and psychologically and had weekly sessions of behavioral therapy. The subjects who received placebo had more symptoms, assessed their symptoms as more severe, and stopped taking the study drug at a higher rate than those receiving the tapering doses of diazepam. The subjects in the placebo group also had symptoms shortly after being switched to placebo, whereas those in the diazepam group had symptoms much later. Some withdrawal symptoms were distinct from those of anxiety (e.g., tinnitus, involuntary movement, and perceptual changes). Withdrawal symptoms occurred earlier in patients who had received short-acting benzodiazepines than in those who had received long-acting benzodiazepines. Symptoms gradually disappeared over a four-week period in both the placebo and the diazepam groups. Serial determination of plasma benzodiazepine concentrations was a useful way to assess compliance, treatment outcome, and relapse during withdrawal. We conclude that a clinically important, mild, but distinct withdrawal syndrome occurs after discontinuation of long-term therapeutic use of benzodiazepines.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198610023151403

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

10 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 38 references

Research works printed but not linked: 5

  1. Petursson H, Lader M. Dependence on tranquilizers. New York: Oxford University Press, 1984.
  2. Kapur, 1975, Clin Chem, 21, 947
  3. Spielberger CD, Gorsuch RL, Lushene RE, Bagg PR, Jacobs GA. Manual for state-trait anxiety inventory. Palo Alto, Calif.: Consulting Psychologists Inc. Press, 1970.
  4. Paitich, 1970, Ontario Psychol, 2, 304
  5. Balter, 1984, Curr Med Res Opin, 8, 5

Cited by

See all 369

Metadata

Authors
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K.
Venue
New England Journal of Medicine
Published
1986-10-02
Volume
315
Issue
14
Pages
854-859
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2335780156
Cited by
369
References
38
Citations by year
2026: 4 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 2 · 2020: 9 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 6 · 2013: 5 · 2012: 10
FWCI
18.26
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
benzodiazepine withdrawal, diazepam, withdrawal symptoms, tinnitus, involuntary movements, perceptual change, short-acting benzodiazepines, long-acting benzodiazepines, medication adherence, relapse, behavior therapy
MeSH terms
Adolescent, Adult, Aged, Anxiety, Benzodiazepines, Diazepam, Double-Blind Method, Female, Flurazepam, Humans, Long-Term Care, Lorazepam, Male, Middle Aged, Oxazepam, Patient Compliance, Placebos, Substance Withdrawal Syndrome, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines. https://app.cochat.ai/papers/10.1056/nejm198610023151403
The paper
Busto, U., Sellers, E. M., Naranjo, C. A., Cappell, H., Sanchez-Craig, M., & Sykora, K. (1986). Withdrawal Reaction after Long-Term Therapeutic Use of Benzodiazepines. New England Journal of Medicine. https://doi.org/10.1056/nejm198610023151403

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.